KAREY SCHMELZ: Open Payments
NPI 1366499790 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 80 payments from 20 companies in 2025. Trend: 2023 $1,590 · 2024 $1,614 · 2025 $1,513
Food & beverage: $1,513
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $214 |
| AstraZeneca Pharmaceuticals LP | 2 | $190 |
| Novo Nordisk Inc | 12 | $189 |
| SANOFI-AVENTIS U.S. LLC | 8 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $163 |
| Otsuka America Pharmaceutical, Inc. | 7 | $142 |
| Exact Sciences Corporation | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| PFIZER INC. | 3 | $46 |
| GlaxoSmithKline, LLC. | 3 | $45 |
Products named: AIRSUPRA, MOUNJARO, TZIELD, Kerendia, REXULTI, Cologuard Collection Kit, Ozempic, LEQVIO.
Industry payments across NY — which companies pay providers there.
